Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 1

Conditions

Burkitt Lymphoma 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Extranodal NK-T-Cell 4Leukemia, Biphenotypic, Acute 3Leukemia 2Down Syndrome 2Lymphohistiocytosis, Hemophagocytic 1

Interventions

Cyclophosphamide 15venetoclax 11fludarabine 10Cytarabine 10Mycophenolic Acid 6Azacitidine 6fludarabine phosphate 5Daunorubicin 5Busulfan 5ruxolitinib 4ponatinib 4blinatumomab 4Whole-Body Irradiation 4Vincristine 4Tacrolimus 4Rituximab 4Methotrexate 4Dexamethasone 4asciminib 3Mercaptopurine 3Inotuzumab Ozogamicin 3Granulocyte Colony-Stimulating Factor 3Cyclosporine 3revumenib 2quizartinib 2pegaspargase 2nilotinib 2ibrutinib 2Thioguanine 2Prednisone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia × pegaspargase × 90 days × Clear all
NCT00558519 2026-04-29

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Alliance for Clinical Trials in Oncology

Phase 2 Completed
318 enrolled 9 charts
Other hematologic neoplasm

Leukemia

NCT02723994 2026-03-11

A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia

Incyte Corporation

Phase 2 Completed
171 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡